Your doctor may also recommend temporarily reducing your Zepbound dose or extending the time between dose increases to allow better tolerance
Protocol 2: the tirzepatide micro-step escalation Goal: Avoid the dramatic side effects common with standard 2.5 mg escalation jumps Schedule (compounded tirzepatide required): Weeks 1-4: 2.5 mg weekly Weeks 5-8: 3.0 mg weekly Weeks 9-12: 3.75 mg weekly Weeks 13-16: 5.0 mg weekly Weeks 17-20: 6.25 mg weekly Weeks 21-24: 7.5 mg weekly Continue escalating by 1.25-2.5 mg every 4 weeks as needed Why the plotter supports this: The standard jump from 2.5 mg to 5 mg produces a transition spike where your first-week peak at 5 mg can exceed the eventual 5 mg steady-state peak by 15-25%
Additionally, the peptide apparently stimulated dermal keratinocyte proliferation, as evidenced by histological analysis of biopsies
Potential role of stem-cell chemokines in type 2 diabetes Experimentally, potentiation of SDF-1 can act to promote pancreatic -cell genesis, differentiation and survival, and the chemokine may protect cells from destruction as diabetes progresses [12, 13]
Interview with Zoe, Lipoedema Patient Advocate and Plus Size Fashion Model Prior to taking Tirzepatide (Mounjaro), Zoe was at peace with how her body looked and so for her, though weight loss has occurred what was important was the difference the drug has made to how her lipoedema FEELS which is what this interview focuses on